The Claim
Statin therapy reduces vascular mortality by 12% and all-cause mortality by 9% per 1.0 mmol/L reduction in LDL cholesterol in individuals without prior vascular disease, with no increase in non-vascular mortality, resulting in a net survival benefit.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people without prior heart or blood vessel disease, taking statins lowers the risk of dying from vascular causes by 12% and from any cause by 9% for every 1.0 mmol/L decrease in LDL cholesterol, with no rise in deaths from other causes.
See the scientific wording
Statin therapy reduces vascular mortality by 12% and all-cause mortality by 9% per 1.0 mmol/L LDL reduction in individuals without prior vascular disease, with no increase in non-vascular mortality, indicating a net survival benefit.
Lowering LDL cholesterol stops fatty buildup in artery walls, hardens existing plaques so they don't rupture, and prevents blood clots from forming, which stops heart attacks and strokes that cause death.
What the research says
1 studyTaking statins to lower cholesterol by 1 mmol/L reduces the chance of dying from heart problems by about 12% and from any cause by 9% in people who’ve never had heart disease, without increasing deaths from other causes like cancer.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.